A Six-Epithelial–Mesenchymal Transition Gene Signature May Predict Metastasis of Triple-Negative Breast Cancer

A Six-Epithelial–Mesenchymal Transition Gene Signature May Predict Metastasis of Triple-Negative Breast Cancer

Li Yuan Wei,1,* Xiao Jun Zhang,1,* Li Wang,2 Li Na Hu,3 Xu Dong Zhang,4,5 Li Li,3 Jin Nan Gao1 1Department of Breast Surgery, Shanxi Bethune Hospital, Taiyuan, People’s Republic of China; 2School of Basic Medicine Sciences, Academy of Medical Science, Zhengzhou University, Henan 450053, Pe...

Full description

Bibliographic Details
Main Authors:	Wei LY, Zhang XJ, Wang L, Hu LN, Zhang XD, Li L, Gao JN
Format:	Article
Language:	English
Published:	Dove Medical Press 2020-07-01
Series:	OncoTargets and Therapy
Subjects:	triple-negative breast cancer neoadjuvant chemotherapy epithelial-mesenchymal transition distant metastasis.
Online Access:	https://www.dovepress.com/a-six-epithelialndashmesenchymal-transition-gene-signature-may-predict-peer-reviewed-article-OTT

Similar Items

A Novel Seven Gene Signature-Based Prognostic Model to Predict Distant Metastasis of Lymph Node-Negative Triple-Negative Breast Cancer
by: Wenting Peng, et al.
Published: (2021-09-01)

Impact of histotypes on preferential organ‐specific metastasis in triple‐negative breast cancer
by: Yaming Li, et al.
Published: (2020-02-01)

Mesenchymal phenotype of circulating tumor cells is associated with distant metastasis in breast cancer patients
by: Zhang SR, et al.
Published: (2017-11-01)

Delta Radiomics Can Predict Distant Metastasis in Locally Advanced Rectal Cancer: The Challenge to Personalize the Cure
by: Giuditta Chiloiro, et al.
Published: (2020-12-01)

Therapeutic Pattern and Progress of Neoadjuvant Treatment for Early Stage Triple-negative Breast Cancer
by: XIU Meng, et al.
Published: (2020-02-01)

Current status and novel directions in triple negative breast cancer patients. Risk factors. Role of the platinum-based chemotherapy
by: Olivia IONESCU, et al.
Published: (2016-06-01)

Phenotypic Heterogeneity of Triple-Negative Breast Cancer Mediated by Epithelial–Mesenchymal Plasticity
by: Barbora Kvokačková, et al.
Published: (2021-05-01)

A Minimal lncRNA-mRNA Signature Predicts Sensitivity to Neoadjuvant Chemotherapy in Triple-Negative Breast Cancer
by: Qian Wang, et al.
Published: (2018-08-01)

Neoadjuvant Treatment for Triple Negative Breast Cancer: Recent Progresses and Challenges
by: Jin Sun Lee, et al.
Published: (2020-05-01)

Postmastectomy radiotherapy reduces locoregional and disease recurrence in patients with stage II–III triple-negative breast cancer treated with neoadjuvant chemotherapy and mastectomy
by: Chen XX, et al.
Published: (2018-04-01)

Neoadjuvant treatments in triple-negative breast cancer patients: where we are now and where we are going
by: Omarini C, et al.
Published: (2018-01-01)

Gene signature‐based prediction of triple‐negative breast cancer patient response to Neoadjuvant chemotherapy
by: Yanding Zhao, et al.
Published: (2020-09-01)

The Association of Tumor-Infiltrating Lymphocytes and Programmed Cell Death 1 Expression with the Incidence of Distant Metastasis in Triple-Negative Breast Cancer Subjects in Sanglah General Hospital, Bali, Indonesia
by: I Wayan Sudarsa, et al.
Published: (2021-03-01)

RPLP1 promotes tumor metastasis and is associated with a poor prognosis in triple-negative breast cancer patients
by: Zhixian He, et al.
Published: (2018-10-01)

Clinical Initial Response of Neoadjuvant Chemotheraphy in Triple Negative, HER-2, and Luminal Types of Breast Cancer in Denpasar (A Preliminary Study)
by: Kristianto Yuli Yarso, et al.
Published: (2012-01-01)

Clinical Initial Response of Neoadjuvant Chemotheraphy in Triple Negative, HER-2, and Luminal Types of Breast Cancer in Denpasar (A Preliminary Study)
by: Kristianto Yuli Yarso, et al.
Published: (2012-01-01)

Cisplatin versus carboplatin in combination with paclitaxel as neoadjuvant regimen for triple negative breast cancer
by: Huang L, et al.
Published: (2017-12-01)

GADD45B Facilitates Metastasis of Ovarian Cancer Through Epithelial–Mesenchymal Transition
by: Gong L, et al.
Published: (2021-01-01)

Deep learning radiomics-based prediction of distant metastasis in patients with locally advanced rectal cancer after neoadjuvant chemoradiotherapy: A multicentre study
by: Xiangyu Liu, et al.
Published: (2021-07-01)

The effect of neoadjuvant platinum-based chemotherapy in BRCA mutated triple negative breast cancers -systematic review and meta-analysis
by: Olga Caramelo, et al.
Published: (2019-03-01)

COMPARATIVE ANALYSIS OF DIFFERENT NEOADJUVANT CHEMOTHERAPY REGIMENS FOR TRIPLE-NEGATIVE BREAST CANCER
by: P. V. Krivorotko, et al.
Published: (2017-12-01)

Bilateral Triple Negative Invasive Ductal Breast Carcinoma in a BRCA1 Mutation Carrier with Discrepant Pathologic Response to Neoadjuvant Chemotherapy
by: Gi Won Shin, et al.
Published: (2020-03-01)

Circulating immune cell dynamics in patients with triple negative breast cancer treated with neoadjuvant chemotherapy
by: Sarah Talamantes, et al.
Published: (2020-10-01)

Tamoxifen reverses epithelial–mesenchymal transition by demethylating miR-200c in triple-negative breast cancer cells
by: Qian Wang, et al.
Published: (2017-07-01)

Relation Between CD8+T Lymphocyte Infiltration and Efficacy of Neoadjuvant Chemotherapy for Triple-negative Breast Cancer
by: KONG Tiandong, et al.
Published: (2021-05-01)

The efficacy of neoadjuvant chemotherapy and survival in older patients with stages II to III triple-negative breast cancer
by: Olga O Gordeeva, et al.
Published: (2019-09-01)

Influence of neoadjuvant chemotherapy on prognosis of patients with synovial sarcoma
by: Yanan Wu, et al.
Published: (2017-05-01)

Survival outcomes of neoadjuvant versus adjuvant chemotherapy in triple-negative breast cancer: a meta-analysis of 36,480 cases
by: Lin-Yu Xia, et al.
Published: (2020-06-01)

Lovastatin Inhibits EMT and Metastasis of Triple-Negative Breast Cancer Stem Cells Through Dysregulation of Cytoskeleton-Associated Proteins
by: Chanjuan Zheng, et al.
Published: (2021-06-01)

PRAME promotes epithelial-to-mesenchymal transition in triple negative breast cancer
by: Ghaneya Al-Khadairi, et al.
Published: (2019-01-01)

BRCAness as an Important Prognostic Marker in Patients with Triple-Negative Breast Cancer Treated with Neoadjuvant Chemotherapy: A Multicenter Retrospective Study
by: Yoshimasa Kosaka, et al.
Published: (2020-02-01)

The CXCL5/CXCR2 axis contributes to the epithelial-mesenchymal transition of nasopharyngeal carcinoma cells by activating ERK/GSK-3β/snail signalling
by: Wen-Ze Qiu, et al.
Published: (2018-04-01)

Luteolin suppresses epithelial-mesenchymal transition and migration of triple-negative breast cancer cells by inhibiting YAP/TAZ activity
by: Dai Cao, et al.
Published: (2020-09-01)

Epigenetic reprogramming of epithelial mesenchymal transition in triple negative breast cancer cells with DNA methyltransferase and histone deacetylase inhibitors
by: Yanrong Su, et al.
Published: (2018-12-01)

OSW‐1 inhibits tumor growth and metastasis by NFATc2 on triple‐negative breast cancer
by: Xiaorong Ding, et al.
Published: (2020-08-01)

Prediction of pathological complete response and prognosis in patients with neoadjuvant treatment for triple-negative breast cancer
by: Paul Gass, et al.
Published: (2018-10-01)

Efficacy and safety of cisplatin and paclitaxel (PlaTax regimen) in the neoadjuvant treatment of patients with stage II–III triple-negative breast cancer
by: O. O. Gordeeva, et al.
Published: (2020-11-01)

Caractérisation moléculaire et immunité des cancers du sein triple-négatifs
by: Bonsang-Kitzis, Hélène
Published: (2018)

The BRCA1ness signature is associated significantly with response to PARP inhibitor treatment versus control in the I-SPY 2 randomized neoadjuvant setting
by: Tesa M. Severson, et al.
Published: (2017-08-01)

Dual inhibition of Wnt and Yes‐associated protein signaling retards the growth of triple‐negative breast cancer in both mesenchymal and epithelial states
by: Andrew Sulaiman, et al.
Published: (2018-04-01)